About the Company
We do not have any company description for Eiger BioPharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EIGR News
Requiem for Eiger Biopharmaceuticals
After 24 years in business, the drug innovator hit the FDA’s approval roadblock.
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib)Patient Access to Zokinvy® to Continue UninterruptedPALO ALTO, Calif., ...
Peninsula biotech files for Chapter 11 bankruptcy protection
Eiger BioPharmaceuticals Inc. filed for Chapter 11 bankruptcy protection, turning its drug approved to treat a rare accelerated aging disease in children into a $26 million "stalking horse ...
Metabolic Diseases-Focused Eiger BioPharmaceuticals Files For Bankruptcy, Stock Nosedives
Monday, Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced that it and its direct subsidiaries have filed voluntary petitions for Chapter 11 protection in the U.S. Bankruptcy Court for the ...
Eiger BioPharmaceuticals Inc (EIGR) Shares Down Despite Recent Market Volatility
The net margin for Eiger BioPharmaceuticals Inc stands at -5.91. The total capital return value is set at -2.14. Equity return is now at value -225.93, with -86.91 for asset returns.
Eiger BioPharmaceuticals, Inc. (72C.F)
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases, today announced that it and ...
Eiger BioPharmaceuticals Inc EIGR
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Metabolic Diseases-Focused Eiger BioPharmaceuticals Files For Bankruptcy, Stock Nosedives
In January, Eiger BioPharmaceuticals and its partner AnGes Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy (lonafarnib) for Hutchinson-Gilford ...
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its direct subsidiaries have filed voluntary petitions for chapter 11 protection under the United States Bankruptcy Code in ...
Eiger BioPharmaceuticals Inc EIGR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...